BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12937415)

  • 1. The sympathetic nervous system is involved in variant Creutzfeldt-Jakob disease.
    Haïk S; Faucheux BA; Sazdovitch V; Privat N; Kemeny JL; Perret-Liaudet A; Hauw JJ
    Nat Med; 2003 Sep; 9(9):1121-3. PubMed ID: 12937415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic prion protein spreading in the peripheral nervous system of a patient with sporadic Creutzfeldt-Jakob disease.
    Favereaux A; Quadrio I; Vital C; Perret-Liaudet A; Anne O; Laplanche JL; Petry KG; Vital A
    Arch Neurol; 2004 May; 61(5):747-50. PubMed ID: 15148153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-synuclein-immunoreactive deposits in human and animal prion diseases.
    Haïk S; Privat N; Adjou KT; Sazdovitch V; Dormont D; Duyckaerts C; Hauw JJ
    Acta Neuropathol; 2002 May; 103(5):516-20. PubMed ID: 11935269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sporadic Creutzfeldt-Jakob disease: phenotypic variability].
    Moreno MJ; Romero J
    Neurologia; 2002; 17(7):366-77. PubMed ID: 12236956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion deposition in olfactory biopsy of sporadic Creutzfeldt-Jakob disease.
    Tabaton M; Monaco S; Cordone MP; Colucci M; Giaccone G; Tagliavini F; Zanusso G
    Ann Neurol; 2004 Feb; 55(2):294-6. PubMed ID: 14755736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of intestinal entry of infectious prion protein in the pathogenesis of variant Creutzfeldt-Jakob disease.
    Ghosh S
    Adv Drug Deliv Rev; 2004 Apr; 56(6):915-20. PubMed ID: 15063598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging pharmacotherapies for Creutzfeldt-Jakob disease.
    Korth C; Peters PJ
    Arch Neurol; 2006 Apr; 63(4):497-501. PubMed ID: 16606761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of cerebellar granule neurons is associated with punctate but not with large focal deposits of prion protein in Creutzfeldt-Jakob disease.
    Faucheux BA; Privat N; Brandel JP; Sazdovitch V; Laplanche JL; Maurage CA; Hauw JJ; Haïk S
    J Neuropathol Exp Neurol; 2009 Aug; 68(8):892-901. PubMed ID: 19606064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease.
    Hilton DA
    J Pathol; 2006 Jan; 208(2):134-41. PubMed ID: 16362983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creutzfeldt-Jakob disease associated with the R208H mutation in the prion protein gene.
    Capellari S; Cardone F; Notari S; Schininà ME; Maras B; Sità D; Baruzzi A; Pocchiari M; Parchi P
    Neurology; 2005 Mar; 64(5):905-7. PubMed ID: 15753435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease.
    Schoch G; Seeger H; Bogousslavsky J; Tolnay M; Janzer RC; Aguzzi A; Glatzel M
    PLoS Med; 2006 Feb; 3(2):e14. PubMed ID: 16354106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BSE and vCJD cause disturbance to uric acid levels.
    Lekishvili T; Sassoon J; Thompsett AR; Green A; Ironside JW; Brown DR
    Exp Neurol; 2004 Nov; 190(1):233-44. PubMed ID: 15473996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles.
    Lewis V; Hill AF; Klug GM; Boyd A; Masters CL; Collins SJ
    Neurology; 2005 Jul; 65(1):113-8. PubMed ID: 16009895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle.
    Kovacs GG; Lindeck-Pozza E; Chimelli L; Araújo AQ; Gabbai AA; Ströbel T; Glatzel M; Aguzzi A; Budka H
    Ann Neurol; 2004 Jan; 55(1):121-5. PubMed ID: 14705121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial relationships between diffuse prion protein deposits and neuronal perikarya in variant Creutzfeldt-Jakob disease.
    Armstrong RA
    Folia Neuropathol; 2013; 51(1):18-25. PubMed ID: 23553133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dilated cardiomyopathy and Creutzfeldt-Jakob disease: evidence for a role of cellular prion protein in the heart?
    Bianchin MM; Walz R; Brentani RR; Martins VR
    Arch Intern Med; 2005 Jul; 165(14):1663-4. PubMed ID: 16043687
    [No Abstract]   [Full Text] [Related]  

  • 17. [Morphological changes and prion accumulation in the cerebellar cortex in Creutzfeldt-Jacob disease].
    Karmysheva VIa; Gulevskaia TS; Pogodina VV
    Arkh Patol; 2007; 69(6):10-5. PubMed ID: 18290372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnostic tools in Creutzfeldt-Jakob disease and other prion disorders.
    Van Everbroeck B; Boons J; De Leenheir E; Lübke U; Cras P
    Expert Rev Mol Diagn; 2004 May; 4(3):351-9. PubMed ID: 15137902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial EEG findings in sporadic and iatrogenic Creutzfeldt-Jakob disease.
    Wieser HG; Schwarz U; Blättler T; Bernoulli C; Sitzler M; Stoeck K; Glatzel M
    Clin Neurophysiol; 2004 Nov; 115(11):2467-78. PubMed ID: 15465434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MM1-type sporadic Creutzfeldt-Jakob disease with unusually prolonged disease duration presenting with panencephalopathic-type pathology.
    Hoshino A; Iwasaki Y; Izumi M; Kimura S; Ibi T; Kitamoto T; Yoshida M; Hashizume Y; Sahashi K
    Neuropathology; 2008 Jun; 28(3):326-32. PubMed ID: 18248577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.